LEADER 01065nam--2200373---450-
001 990003596190203316
005 20111124104737.0
010   $a88-7741-882-6
035   $a000359619
035   $aUSA01000359619
035   $a(ALEPH)000359619USA01
035   $a000359619
100   $a20111124d1995----km-y0itay50------ba
101   $aita
102   $aIT
105   $a||||||||001yy
200 1 $a<<I>> mercenari nel mondo greco, 1$edalle origini alla fine del V sec. a.C.$fMarco Bettalli
210   $aPisa$cETS$d1995
215   $a176 p.$cill.$d22 cm
225 2 $aStudi e testi di storia antica$v5
410  0$12001$aStudi e testi di storia antica$v5
454  1$12001
461  1$1001-------$12001
606 0 $aSoldati$xmercenariato$2BNCF
676   $a355.1
700  1$aBETTALLI,$bMarco$0298528
801  0$aIT$bsalbc$gISBD
912   $a990003596190203316
951   $aHPG 129$b5907 DSA
959   $aBK
969   $aDSA
979   $aDSA$b90$c20111124$lUSA01$h1047
996   $aMercenari nel mondo greco, 1$91135268
997   $aUNISA

LEADER 02536nam  22006014a 450 
001 9910144118403321
005 20170810183318.0
010   $a1-281-81450-4
010   $a9786611814502
010   $a0-470-37061-0
010   $a0-470-36916-7
035   $a(CKB)1000000000549398
035   $a(EBL)362144
035   $a(OCoLC)264714700
035   $a(SSID)ssj0000141603
035   $a(PQKBManifestationID)11136183
035   $a(PQKBTitleCode)TC0000141603
035   $a(PQKBWorkID)10058463
035   $a(PQKB)11515335
035   $a(MiAaPQ)EBC362144
035   $a(PPN)198275242
035   $a(EXLCZ)991000000000549398
100   $a20071209d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aDrug-DNA interactions$b[electronic resource] $estructures and spectra /$fKazuo Nakamoto, Masamichi Tsuboi, Gary D. Strahan
210   $aHoboken, N.J. $cJohn Wiley & Sons$dc2008
215   $a1 online resource (396 p.)
300   $aDescription based upon print version of record.
311   $a0-471-78626-8 
320   $aIncludes bibliographical references and index.
327   $aDNA structures and spectra -- Intercalating drugs -- Groove-binding drugs -- Covalent bonding drugs -- Strand-breaking drugs -- Metal-containing drugs.
330   $aLearn vital information about drug-DNA interactions from Drug-DNA Interactions: Structures and Spectra, the only comprehensive book written about this topic. Understand the types of structural and bonding information that can be obtained using specific physico-chemical methods and discover how to design new drugs that are more effective than current treatments and have fewer side effects. Find detailed information about X-ray crystallography, NMR spectroscopy, molecular modeling, and optical spectroscopy such as UV-Visible absorption, fluorescence, circular dichroism (CD), flow linear d
606   $aDNA-drug interactions$xResearch$xMethodology
606   $aDNA$xSpectra
606   $aDrugs$xSpectra
615  0$aDNA-drug interactions$xResearch$xMethodology.
615  0$aDNA$xSpectra.
615  0$aDrugs$xSpectra.
676   $a572.8/6
700   $aNakamoto$b Kazuo$f1922-$023085
701   $aTsuboi$b Masamichi$f1925-$092535
701   $aStrahan$b Gary D$0928917
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910144118403321
996   $aDrug-DNA interactions$92087723
997   $aUNINA